Healthmatters: A Continuing Medical Education Company 

   |  About HealthmattersCME  |  CME Council  |  Contact

« Back to Psychiatry/Neurology

State-of-the-Art Care and Treatment of the Patient with Duchenne Muscular Dystrophy: Now and in the Future

Format
: Internet Activity
Topic
:
Psychiatry/Neurology
Credits
: 2.0 AMA PRA Category 1 Credits, 2.0 contact hours
Target Audience
: Physicians, PAs, Nurse practitioners, Registered Nurses
Expiration Date
: 11/30/2016

Read the content below to launch the activity

RELEASE DATE:
November 30, 2015
 

EXPIRATION DATE:
November 30, 2016
 

TARGET AUDIENCE:
The primary target audience is pediatric or child neurologists and nurses responsible for the care of patients with DMD at MDA centers/clinics.

PROGRAM OVERVIEW:
Clinicians caring for individuals with such neuromuscular diseases as Duchenne Muscular Dystrophy (DMD) may have difficulty remaining current with the evolving standards of care. In addition to DMD, there are more than 90 diseases classified among the inherited neuromuscular disorders, all of them rare. Perhaps because of this complexity, there remains a variability in care across the country even for DMD, the most common disorder. Current management approaches rely heavily on corticosteroids and nonpharmacologic interventions, such as physical therapy. As new therapies become possible, the neuromuscular clinician must have a sound working knowledge of the molecular basis for DMD in order to advise families about potential treatments or clinical trials. Furthermore, the anticipated availability of new therapies will have a substantial impact on treatment strategies and should provide the incentive for expanded, earlier genetic testing leading to earlier diagnosis and treatment. More intensive disease monitoring and cardiac care for the patient with DMD may best be done using protocol-driven interventions so that boys with DMD may remain ambulatory and live longer. In this CME activity, experts in the care of the patient with DMD will discuss state-of-the-art approaches to genetic testing, baseline testing for the patient first presenting with DMD, optimizing the use of corticosteroids in the treatment of the patient with DMD, investigational agents on the horizon and potential clinical applications, and best cardiac care for the patient with DMD.

EDUCATIONAL OBJECTIVES:
  •  Explain current diagnostic approaches to DMD, including DNA testing, laboratory studies, and histologic findings
  •  Describe best practices for baseline clinical testing of patients with DMD in the neuromuscular clinic which may guide both treatment and trial participation
  •  Describe corticosteroid guidelines including treatment regimens, age of treatment, and side effects
  •  Discuss investigational therapies under development for DMD and the potential for integrating different mechanisms of action into treatment strategies
  •  Provide an update on gene therapy and stem cell therapy
  •  Review best practices for cardiac care of boys and men with DMD

CME/CE INFORMATION:
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and HealthmattersCME. Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation:
Global Education Group designates this enduring activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
NURSING CONTINUING EDUCATION:
Global Education Group is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
 
This educational activity for 2.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
 
DISCLOSURE OF CONFLICTS OF INTEREST:
Global Education Group (Global) requires instructors, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COIs are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient-care recommendations.
For information about the accreditation of this program, please contact Global at 303-395-1782303-395-1782303-395-1782orinquire@globaleducationgroup.com.

FACULTY:
Anne M. Connolly, MD, Chair
Professor of Neurology and Pediatrics
Washington University in St. Louis School of Medicine
Pediatric Neurologist
St. Louis Children’s Hospital
Barnes-Jewish Hospital
St. Louis, MO

Linda H. Cripe, MD
Professor of Pediatrics
The Heart Center
Nationwide Children’s Hospital
The Ohio State University
Columbus, OH

Valerie Cwik, MD
Executive Vice President
Chief Medical and Scientific Officer
Muscular Dystrophy Association
Tucson, AZ

Jerry R. Mendell, MD

Professor of Pediatrics, Neurology, and Pathology
The Ohio State University College of Medicine
Director, Center for Gene Therapy
Nationwide Children’s Hospital
Columbus, OH

Perry B. Shieh, MD, PhD
Associate Professor of Neurology
Director, Neuromuscular Division
David Geffen School of Medicine at UCLA
Los Angeles, CA

DISCLOSURES: 
THE FACULTY REPORTED THE FOLLOWING FINANCIAL RELATIONSHIPS OR RELATIONSHIPS TO PRODUCTS OR DEVICES THEY OR THEIR SPOUSE/LIFE PARTNER HAVE WITH COMMERCIAL INTERESTS RELATED TO THE CONTENT OF THIS CME ACTIVITY:

Anne M. Connolly, MD
Consultant/Independent Contractor: BioMarin Pharmaceutical; Cytokinetics; Fibrogen; Roche; Sarepta Therapeutics; Summit

Linda H. Cripe, MD
Nothing to disclose

Valerie Cwik, MD
Nothing to disclose

Jerry R. Mendell, MD
Nothing to disclose

Perry B. Shieh, MD, PhD
Consultant Independent Contractor: BioMarin Pharmaceutical; Marathon Pharmaceuticals; PTC Therapeutics; Sarepta Therapeutics

PLANNERS/MANAGERS: 
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Amanda Glazar, PhD
Nothing to disclose

Ashley Marostica, RN, MSN
Nothing to disclose

Andrea Funk
Nothing to disclose

James Murphy
Nothing to Disclose

REQUEST FOR CREDIT:
In order to receive credit for this activity, the participant must listen to the entire activity and then complete the post-survey, post-test, evaluation, and request for credit.

DISCLOSURE OF UNLABELED USE:
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and HealthmattersCME do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER:
This activity is jointly provided by Global Education Group and HealthmattersCME in association with the Muscular Dystrophy Association
This activity is supported by an independent educational grant from Sarepta Therapeutics.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

FEE INFORMATION & REFUND/CANCELLATION POLICY:
There is no fee for this educational activity.

SYSTEM REQUIREMENTS:
PC
Windows XP or above
Internet Explorer (v7 or greater), Safari, FireFox, or Chrome

MAC
MAC OSX 10.6.1 or above
Safari, FireFox, or Chrome

This activity is jointly provided by Global Education Group and HealthmattersCME in association with the Muscular Dystrophy Association

This activity is supported by an independent educational grant from Sarepta Therapeutics.

 

Stay Informed

Please click here to register if you would like to be added to our mailing list to receive information on educational materials.

Sign Up Now

Certification


wbenc.org

Accreditation




iatan.com

Stay Informed

Close this box
required required
Invalid Email required
required required
required
Submit Close